While non-BP-related mechanisms, such as cardiovascular remodelling, have been proposed to explain FGF5’s role in CVD,62 our findings suggest that a significant proportion of its effect on CHD and ischaemic stroke is mediated through BP regulation. The gene discussed is FGF5; the disease is ischemic stroke.